BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38709774)

  • 1. Antitumor Activity and Mechanistic Insights of a Mitochondria-Targeting Cu(I) Complex.
    Xu S; Hao Y; Xu X; Huang L; Liang Y; Liao J; Yang JR; Zhou Y; Huang M; Du KZ; Zhang C; Xu P
    J Med Chem; 2024 May; 67(10):7911-7920. PubMed ID: 38709774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Cu(II) 4-hydroxybenzoylhydrazone complexes that induce mitochondrial DNA damage and mitochondria-mediated apoptosis in liver cancer.
    Jiang M; Yan Q; Fu Y; Meng L; Gai S; Pan X; Qin Y; Jiang C
    J Inorg Biochem; 2024 Jul; 256():112550. PubMed ID: 38599004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria.
    Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J
    Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antitumor mechanisms of a copper(II) complex of anthracene-9-imidazoline hydrazone (9-AIH).
    Qin QP; Liu YC; Wang HL; Qin JL; Cheng FJ; Tang SF; Liang H
    Metallomics; 2015 Jul; 7(7):1124-36. PubMed ID: 25904543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first copper(I) complex of anthrahydrazone with potential ROS scavenging activity showed significant in vitro anticancer activity by inducing apoptosis and autophagy.
    Liu RX; Luo RY; Tang MT; Liu YC; Chen ZF; Liang H
    J Inorg Biochem; 2021 May; 218():111390. PubMed ID: 33721719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro antitumor activity evaluation of copper(II) complexes with 5-pyridin-2-yl-[1,3]dioxolo[4,5-g]isoquinoline derivatives.
    Zhang YL; Deng CX; Zhou WF; Zhou LY; Cao QQ; Shen WY; Liang H; Chen ZF
    J Inorg Biochem; 2019 Dec; 201():110820. PubMed ID: 31518871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria-localizing triphenylphosphine-8-hydroxyquinoline Ru complexes induce ferroptosis and their antitumor evaluation.
    Meng T; Xu Z; Wang HJ; Huang J; Wen JL; Huang MP; Zhou CY; Zhong JP
    J Inorg Biochem; 2024 Aug; 257():112585. PubMed ID: 38718498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper(II) and iron(III) complexes of chiral dehydroabietic acid derived from natural rosin: metal effect on structure and cytotoxicity.
    Fei BL; Hui CN; Wei Z; Kong LY; Long JY; Qiao C; Chen ZF
    Metallomics; 2021 Apr; 13(4):. PubMed ID: 33765148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemodynamic therapy agents Cu(II) complexes of quinoline derivatives induced ER stress and mitochondria-mediated apoptosis in SK-OV-3 cells.
    Shen WY; Jia CP; Mo AN; Liang H; Chen ZF
    Eur J Med Chem; 2021 Nov; 223():113636. PubMed ID: 34175540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elaborated study of Cu(II) carbosilane metallodendrimers bearing substituted iminopyridine moieties as antitumor agents.
    Carloni R; Sanz Del Olmo N; Canonico B; Montanari M; Ciacci C; Ambrosi G; de la Mata FJ; Ottaviani MF; García-Gallego S
    Eur J Med Chem; 2021 Apr; 215():113292. PubMed ID: 33631696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA binding, cleavage and cytotoxicity studies of three mononuclear Cu(II) chloro-complexes containing N-S donor Schiff base ligands.
    Parsekar SU; Fernandes J; Banerjee A; Chouhan OP; Biswas S; Singh M; Mishra DP; Kumar M
    J Biol Inorg Chem; 2018 Dec; 23(8):1331-1349. PubMed ID: 30302601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cu(I) complexes as new antiproliferative agents against sensitive and doxorubicin resistant colorectal cancer cells: synthesis, characterization, and mechanisms of action.
    Sequeira D; Baptista PV; Valente R; Piedade MFM; Garcia MH; Morais TS; Fernandes AR
    Dalton Trans; 2021 Feb; 50(5):1845-1865. PubMed ID: 33470993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syntheses, Crystal Structures, and Antitumor Activities of Copper(II) and Nickel(II) Complexes with 2-((2-(Pyridin-2-yl)hydrazono)methyl)quinolin-8-ol.
    Yang QY; Cao QQ; Qin QP; Deng CX; Liang H; Chen ZF
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29949884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
    Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW
    J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optically pure chiral copper(II) complexes of rosin derivative as attractive anticancer agents with potential anti-metastatic and anti-angiogenic activities.
    Fei BL; Tu S; Wei Z; Wang P; Qiao C; Chen ZF
    Eur J Med Chem; 2019 Aug; 176():175-186. PubMed ID: 31103898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of catacholase mimicking activity and apoptosis in human colorectal carcinoma cell line by activating mitochondrial pathway of copper(II) complex coupled with 2-(quinolin-8-yloxy)(methyl)benzonitrile and 8-hydroxyquinoline.
    Ali A; Mishra S; Kamaal S; Alarifi A; Afzal M; Saha KD; Ahmad M
    Bioorg Chem; 2021 Jan; 106():104479. PubMed ID: 33272712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria-targeted ruthenium complexes can be generated in vitro and in living cells to target triple-negative breast cancer cells by autophagy inhibition.
    Zhang GD; Wang MM; Su Y; Fang H; Xue XL; Liu HK; Su Z
    J Inorg Biochem; 2024 Jul; 256():112574. PubMed ID: 38677004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of resveratrol is independent of Cu(II) complex formation in MCF-7 cell line.
    Andrade Volkart P; Benedetti Gassen R; Mühlen Nogueira B; Nery Porto B; Eduardo Vargas J; Arigony Souto A
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3238-3242. PubMed ID: 28647350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer potency of copper(II) complexes of thiosemicarbazones.
    Singh NK; Kumbhar AA; Pokharel YR; Yadav PN
    J Inorg Biochem; 2020 Sep; 210():111134. PubMed ID: 32673842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the introduction of a triphenylphosphine group on the anticancer activity of a copper complex.
    Li S; Zhao J; Guo Y; Mei Y; Yuan B; Gan N; Zhang J; Hu J; Hou H
    J Inorg Biochem; 2020 Sep; 210():111102. PubMed ID: 32574870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.